TCL Archive Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms April 6, 2012
TCL Archive Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal December 16, 2011